A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Clinical trial NCT02780141 · COMPLETED
Trial details
- NCT number
- NCT02780141
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-02
- Primary completion
- 2017-12-12
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.